259 related articles for article (PubMed ID: 12426980)
21. Nonsteroidal therapy for idiopathic pulmonary fibrosis.
Baughman RP; Alabi FO
Curr Opin Pulm Med; 2001 Sep; 7(5):309-13. PubMed ID: 11584181
[TBL] [Abstract][Full Text] [Related]
22. Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia.
Kondoh Y; Taniguchi H; Yokoi T; Nishiyama O; Ohishi T; Kato T; Suzuki K; Suzuki R
Eur Respir J; 2005 Mar; 25(3):528-33. PubMed ID: 15738299
[TBL] [Abstract][Full Text] [Related]
23. Interstitial lung disease in systemic sclerosis.
Bussone G; Mouthon L
Autoimmun Rev; 2011 Mar; 10(5):248-55. PubMed ID: 20863911
[TBL] [Abstract][Full Text] [Related]
24. Colchicine, cyclophosphamide and prednisone in the treatment of mild-moderate idiopathic pulmonary fibrosis: comparison of three currently available therapeutic regimens.
Fiorucci E; Lucantoni G; Paone G; Zotti M; Li BE; Serpilli M; Regimenti P; Cammarella I; Puglisi G; Schmid G
Eur Rev Med Pharmacol Sci; 2008; 12(2):105-11. PubMed ID: 18575160
[TBL] [Abstract][Full Text] [Related]
25. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
Hoyles RK; Ellis RW; Wellsbury J; Lees B; Newlands P; Goh NS; Roberts C; Desai S; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM
Arthritis Rheum; 2006 Dec; 54(12):3962-70. PubMed ID: 17133610
[TBL] [Abstract][Full Text] [Related]
26. [Therapy of diffuse pulmonary fibrosis (including prevention of development and progression)].
Dierkesmann R; Cegla UH; Meier-Sydow J; Kroidl R
Internist (Berl); 1974 Jul; 15(7):386-90. PubMed ID: 4608973
[No Abstract] [Full Text] [Related]
27. Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis.
Antoniou KM; Nicholson AG; Dimadi M; Malagari K; Latsi P; Rapti A; Tzanakis N; Trigidou R; Polychronopoulos V; Bouros D
Eur Respir J; 2006 Sep; 28(3):496-504. PubMed ID: 16611657
[TBL] [Abstract][Full Text] [Related]
28. Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).
Naccache JM; Montil M; Cadranel J; Cachanado M; Cottin V; Crestani B; Valeyre D; Wallaert B; Simon T; Nunes H
BMC Pulm Med; 2019 Apr; 19(1):75. PubMed ID: 30971235
[TBL] [Abstract][Full Text] [Related]
29. Cyclophosphamide in the treatment of idiopathic pulmonary fibrosis: a prospective study in patients who failed to respond to corticosteroids.
Zisman DA; Lynch JP; Toews GB; Kazerooni EA; Flint A; Martinez FJ
Chest; 2000 Jun; 117(6):1619-26. PubMed ID: 10858393
[TBL] [Abstract][Full Text] [Related]
30. [Early treatment of IgA nephritis is indicated by prognostic factors].
Barth C
Dtsch Med Wochenschr; 2000 Aug; 125(34-35):1009. PubMed ID: 11004913
[No Abstract] [Full Text] [Related]
31. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Azuma A; Nukiwa T; Tsuboi E; Suga M; Abe S; Nakata K; Taguchi Y; Nagai S; Itoh H; Ohi M; Sato A; Kudoh S
Am J Respir Crit Care Med; 2005 May; 171(9):1040-7. PubMed ID: 15665326
[TBL] [Abstract][Full Text] [Related]
32. [Therapy for idiopathic interstitial pneumonias: steroids--and what else?].
Prasse A; Müller-Quernheim J
Internist (Berl); 2006 Dec; 47(12):1258-62. PubMed ID: 17102999
[TBL] [Abstract][Full Text] [Related]
33. Idiopathic pulmonary fibrosis.
Balamugesh T; Behera D
J Assoc Physicians India; 2007 May; 55():363-70. PubMed ID: 17844698
[TBL] [Abstract][Full Text] [Related]
34. Corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: a single center experience and literature review.
Novelli L; Ruggiero R; De Giacomi F; Biffi A; Faverio P; Bilucaglia L; Gamberini S; Messinesi G; Pesci A
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):385-391. PubMed ID: 28079851
[TBL] [Abstract][Full Text] [Related]
35. Recognition and treatment of idiopathic pulmonary fibrosis.
Nicod LP
Drugs; 1998 Apr; 55(4):555-62. PubMed ID: 9561344
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic intervention: assessing the role of the international consensus guidelines.
Nathan SD
Chest; 2005 Nov; 128(5 Suppl 1):533S-539S. PubMed ID: 16304244
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary fibrosis.
Zisman DA; Keane MP; Belperio JA; Strieter RM; Lynch JP
Methods Mol Med; 2005; 117():3-44. PubMed ID: 16130230
[TBL] [Abstract][Full Text] [Related]
38. [Pulmonary fibrosis. Classification, diagnosis, therapy].
Costabel U; Guzman J
Internist (Berl); 2003 Jun; 44 Suppl 1():S35-43. PubMed ID: 14567087
[TBL] [Abstract][Full Text] [Related]
39. [Clinical experience with pirfenidone for the treatment of idiopathic pulmonary fibrosis].
Bonella F; Wessendorf TE; Costabel U
Dtsch Med Wochenschr; 2013 Mar; 138(11):518-23. PubMed ID: 23423955
[TBL] [Abstract][Full Text] [Related]
40. Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis.
Collard HR; Ryu JH; Douglas WW; Schwarz MI; Curran-Everett D; King TE; Brown KK
Chest; 2004 Jun; 125(6):2169-74. PubMed ID: 15189938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
